The patent badge is an abbreviated version of the USPTO patent document. The patent badge does contain a link to the full patent document.

The patent badge is an abbreviated version of the USPTO patent document. The patent badge covers the following: Patent number, Date patent was issued, Date patent was filed, Title of the patent, Applicant, Inventor, Assignee, Attorney firm, Primary examiner, Assistant examiner, CPCs, and Abstract. The patent badge does contain a link to the full patent document (in Adobe Acrobat format, aka pdf). To download or print any patent click here.

Date of Patent:
Feb. 20, 2024

Filed:

Jan. 07, 2021
Applicant:

Banner Life Sciences Llc, High Point, NC (US);

Inventors:

Franck S. F. Rousseau, Chapel Hill, NC (US);

Thomas Wallace Lategan, New Orleans, LA (US);

Tiffany Nicole Sprague, Greensboro, NC (US);

Jason Michael Vaughn, Maineville, OH (US);

Justin Roy Hughey, Asheboro, NC (US);

Assignee:

BANNER LIFE SCIENCES LLC, High Point, NC (US);

Attorney:
Primary Examiner:
Int. Cl.
CPC ...
A61K 31/22 (2006.01); A61K 9/00 (2006.01); A61P 1/12 (2006.01); A61K 9/48 (2006.01); A61P 1/08 (2006.01);
U.S. Cl.
CPC ...
A61K 31/22 (2013.01); A61K 9/0053 (2013.01); A61K 9/4808 (2013.01); A61K 9/4825 (2013.01); A61K 9/4858 (2013.01); A61K 9/4866 (2013.01); A61P 1/08 (2018.01); A61P 1/12 (2018.01);
Abstract

Described herein are pharmaceutical compositions comprising one or more fumarate esters and methods for treating multiple sclerosis subjects with the compositions where the incidence of gastrointestinal side effects is reduced compared to treatments comprising dimethyl fumarate (e.g., TECFIDERA®). In particular, described herein are oral pharmaceutical compositions comprising monomethyl fumarate in a liquid vehicle that have reduced gastrointestinal side effects.


Find Patent Forward Citations

Loading…